Raltitrexed
Key facts
| Invented name |
Tomudex
|
| Active substance |
Raltitrexed
|
| Therapeutic area |
Oncology
|
| Decision number |
P/17/2009
|
| PIP number |
Raltitrexed
|
| Pharmaceutical form(s) |
Powder for solution for injection or infusion
|
| Condition(s) / indication(s) |
Mesothelioma of the pleura
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Hospira UK Limited
E-mail: medinfouk@hospira.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|